These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6085754

  • 41. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W, Chubb S, Alexander L, Montgomery JA.
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract] [Full Text] [Related]

  • 42. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Res; 1988 Jan 15; 48(2):329-34. PubMed ID: 3335008
    [Abstract] [Full Text] [Related]

  • 43. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS, Plunkett W.
    Cancer Res; 1982 Sep 15; 42(9):3637-41. PubMed ID: 6179604
    [Abstract] [Full Text] [Related]

  • 44. Effects of cis-malonato-diammino platinum (II) on P-388 lymphocytic leukemia cell metabolism.
    Hall IH, Holshouser MH, Loeffler LJ.
    J Pharm Sci; 1980 Oct 15; 69(10):1160-3. PubMed ID: 7420282
    [Abstract] [Full Text] [Related]

  • 45. Antitumor agents XLVI: In vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells.
    Hall IH, Liou YF, Okano M, Lee KH.
    J Pharm Sci; 1982 Mar 15; 71(3):345-8. PubMed ID: 7069596
    [Abstract] [Full Text] [Related]

  • 46. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis.
    Chitnis MP, Johnson RK.
    J Natl Cancer Inst; 1978 May 15; 60(5):1049-54. PubMed ID: 642026
    [Abstract] [Full Text] [Related]

  • 47. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW, Cheng YC, Schabel FM, Montgomery JA.
    Cancer Res; 1980 Oct 15; 40(10):3610-5. PubMed ID: 6254636
    [Abstract] [Full Text] [Related]

  • 48. Metabolism and action of fludarabine phosphate.
    Plunkett W, Huang P, Gandhi V.
    Semin Oncol; 1990 Oct 15; 17(5 Suppl 8):3-17. PubMed ID: 1699280
    [Abstract] [Full Text] [Related]

  • 49. Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
    Hutton JJ, Von Hoff DD, Kuhn J, Phillips J, Hersh M, Clark G.
    Cancer Res; 1984 Sep 15; 44(9):4183-6. PubMed ID: 6204752
    [Abstract] [Full Text] [Related]

  • 50. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T, Nagahata T, Arakawa M, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Jul 15; 17(7):1351-6. PubMed ID: 2114829
    [Abstract] [Full Text] [Related]

  • 51. 9-beta-D-arabinofuranosyl-adenine 5' monophosphate coupled to lactosaminated albumin is not metabolized in mouse bloodstream.
    Fiume L, Balboni PG, Bassi B, Busi C, Mattioli A, Spinosa G.
    Pharm Acta Helv; 1986 Jul 15; 61(12):342-4. PubMed ID: 2433700
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3'-5' exonuclease activity and its role in araAMP incorporation.
    Derse D, Cheng YC.
    J Biol Chem; 1981 Aug 25; 256(16):8525-30. PubMed ID: 6167579
    [Abstract] [Full Text] [Related]

  • 54. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
    Huang P, Plunkett W.
    Mol Pharmacol; 1991 Apr 25; 39(4):449-55. PubMed ID: 1708088
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.
    Powis G, Harris RN, Basseches PJ, Santone KS.
    Cancer Chemother Pharmacol; 1986 Apr 25; 16(1):43-9. PubMed ID: 3940219
    [Abstract] [Full Text] [Related]

  • 57. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
    Sonawat HM, Leibfritz D, Engel J, Hilgard P.
    Biochim Biophys Acta; 1990 Apr 09; 1052(1):36-41. PubMed ID: 2322593
    [Abstract] [Full Text] [Related]

  • 58. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC, Derse D, Cheng YC, Brockman RW, Bennett LL.
    Mol Pharmacol; 1982 Mar 09; 21(2):474-7. PubMed ID: 7048062
    [Abstract] [Full Text] [Related]

  • 59. [Effect of oridonin and bleomycin A5 combination on DNA syntheses in tumor and bone marrow cells].
    Shou MG, Wang MY, Wang Q, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1987 Jan 09; 8(1):83-6. PubMed ID: 2440237
    [No Abstract] [Full Text] [Related]

  • 60. Effect of induced acidosis on cytotoxicity of anticancer drugs.
    Adwankar M, Juvekar A, Chitnis M.
    Sel Cancer Ther; 1991 Jan 09; 7(1):1-7. PubMed ID: 1925115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.